167 related articles for article (PubMed ID: 27058904)
1. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
[TBL] [Abstract][Full Text] [Related]
2. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA
Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262
[TBL] [Abstract][Full Text] [Related]
3. Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
Hull MA; Ow PL; Ruddock S; Brend T; Smith AF; Marshall H; Song M; Chan AT; Garrett WS; Yilmaz O; Drew DA; Collinson F; Cockbain AJ; Jones R; Loadman PM; Hall PS; Moriarty C; Cairns DA; Toogood GJ
BMJ Open; 2023 Nov; 13(11):e077427. PubMed ID: 38030258
[TBL] [Abstract][Full Text] [Related]
4. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Cockbain AJ; Volpato M; Race AD; Munarini A; Fazio C; Belluzzi A; Loadman PM; Toogood GJ; Hull MA
Gut; 2014 Nov; 63(11):1760-8. PubMed ID: 24470281
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
[TBL] [Abstract][Full Text] [Related]
6. Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.
Watson H; Cockbain AJ; Spencer J; Race A; Volpato M; Loadman PM; Toogood GJ; Hull MA
Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():60-66. PubMed ID: 27914515
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
8. Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence.
Fukunaga M; Mimori K; Masuda T; Hu Q; Yamada K; Mori M
Surg Today; 2021 Oct; 51(10):1671-1681. PubMed ID: 33797637
[TBL] [Abstract][Full Text] [Related]
9. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
Piazzi G; D'Argenio G; Prossomariti A; Lembo V; Mazzone G; Candela M; Biagi E; Brigidi P; Vitaglione P; Fogliano V; D'Angelo L; Fazio C; Munarini A; Belluzzi A; Ceccarelli C; Chieco P; Balbi T; Loadman PM; Hull MA; Romano M; Bazzoli F; Ricciardiello L
Int J Cancer; 2014 Nov; 135(9):2004-13. PubMed ID: 24676631
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum chemokine (C-C motif) ligand 2 levels and prognosis in colorectal cancer.
Szczepanik AM; Siedlar M; Szura M; Kibil W; Brzuszkiewicz K; Brandt P; Kulig J
Pol Arch Med Wewn; 2015; 125(6):443-51. PubMed ID: 26020569
[TBL] [Abstract][Full Text] [Related]
12. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
13. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
Read JA; Beale PJ; Volker DH; Smith N; Childs A; Clarke SJ
Support Care Cancer; 2007 Mar; 15(3):301-7. PubMed ID: 17021855
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases.
Al-Taan O; Stephenson JA; Spencer L; Pollard C; West AL; Calder PC; Metcalfe M; Dennison AR
Lipids Health Dis; 2013 May; 12():64. PubMed ID: 23648075
[TBL] [Abstract][Full Text] [Related]
15. Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients.
Tutino V; De Nunzio V; Caruso MG; Veronese N; Lorusso D; Di Masi M; Benedetto ML; Notarnicola M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027294
[TBL] [Abstract][Full Text] [Related]
16. Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.
Hawcroft G; Loadman PM; Belluzzi A; Hull MA
Neoplasia; 2010 Aug; 12(8):618-27. PubMed ID: 20689756
[TBL] [Abstract][Full Text] [Related]
17. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.
Fini L; Piazzi G; Ceccarelli C; Daoud Y; Belluzzi A; Munarini A; Graziani G; Fogliano V; Selgrad M; Garcia M; Gasbarrini A; Genta RM; Boland CR; Ricciardiello L
Clin Cancer Res; 2010 Dec; 16(23):5703-11. PubMed ID: 21030497
[TBL] [Abstract][Full Text] [Related]
18. Potential Application of Eicosapentaenoic Acid Monoacylglyceride in the Management of Colorectal Cancer.
Morin C; Rodríguez E; Blier PU; Fortin S
Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28869531
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages.
Jinno Y; Nakakuki M; Kawano H; Notsu T; Mizuguchi K; Imada K
Atherosclerosis; 2011 Dec; 219(2):566-72. PubMed ID: 22018640
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects.
Pisaniello AD; Psaltis PJ; King PM; Liu G; Gibson RA; Tan JT; Duong M; Nguyen T; Bursill CA; Worthley MI; Nicholls SJ; Di Bartolo BA
Atherosclerosis; 2021 May; 324():27-37. PubMed ID: 33812168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
